Search clinical trials for: KBP-5209

Total 1020 results

Sihuan Pharmaceutical Holdings Group Ltd.
Covance; XuanZhu Pharma Co., Ltd.

Completed

A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
Kyuzi Kamoi

Not yet recruiting

20 Years Results by HBP and DBP in Patients With Type 2 Diabetes Mellitus After Following-up

Diabetes Mellitus
Nagaoka Red Cross Hospital

Unknown

Long-term of 10 Years Results of a Prospective Longitudinal Study

Type 2 Diabetes Mellitus | Blood Pressure

Japan
Dong-A ST Co., Ltd.

Completed

Bioequivalence Study Between "DA-5209 Tab" and "Lixiana Tab"

Healthy

Korea, Republic of
Massachusetts General Hospital
Patient-Centered Outcomes Research Institute; Dartmouth College; Advocates; Bay... and other collaborators

Recruiting

Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings

Covid19 | Intellectual Disability | Mental Illness | Developmental Disability | Axis I Diagnosis | Coronavirus

United States
Nagaoka Red Cross Hospital

Completed

A Cohort Study of Morning Home Blood Pressure Measurement in Type 2 Diabetic Patients

Hypertension | Type 2 Diabetes
Taipei Veterans General Hospital, Taiwan

Unknown

Guiding Hypertension Management Using Different Blood Pressure Monitoring Strategies (GYMNs)

Hypertension

Taiwan
KBP Biosciences
Covance

Completed

Mass Balance Study of KBP-5074 in Healthy Male Subjects

Healthy

United States
KBP Biosciences

Completed

Phase 1 Single Ascending Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of KBP-5074

Healthy
Dong-A ST Co., Ltd.

Completed

Pharmacokinetics and Safety/Tolerability Profiles of DA-5206 Versus Talion® Under Fasting and Fed States in Healthy Male Subjects

Healthy

Korea, Republic of
Addpharma Inc.

Completed

A Study to Evaluate the Efficacy and Safety of AD-209

Hypertension, Essential

Korea, Republic of
Samik Pharmaceutical Co. Ltd.

Completed

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of SIPS-2209-1 in Healthy Korean Volunteers

Healthy

Korea, Republic of
KBP Biosciences
Covance

Completed

Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic Impairment

Healthy | Moderate Hepatic Impairment

United States
KBP Biosciences
Worldwide Clinical Trials

Completed

Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease (BLOCKCKD)

Hypertension | Chronic Kidney Diseases

United States
Dong-A ST Co., Ltd.

Completed

Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee

Osteoarthritis, Knee

Korea, Republic of
Jiangsu HengRui Medicine Co., Ltd.

Completed

Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage

Primary Hypercholesterolemia | Mixed Hyperlipemia

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

SHR - 1209 Treatment Efficacy and Safety of the Patients With Hypercholesterolemia Ⅲ Period Clinical Research

Primary Hypercholesterolemia

China
KBP Biosciences

Completed

A Multiple Ascending Dose Study of KBP-7072 in Healthy Subjects

Healthy

United States
Dong-A ST Co., Ltd.

Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis

Gastritis Acute | Gastritis Chronic

Korea, Republic of
YourChoice Therapeutics, Inc.

Recruiting

First in Human Study Evaluating Single Ascending Oral Doses of YCT-529 in Healthy Males

Male Contraception

United Kingdom
Jiangsu HengRui Medicine Co., Ltd.

Completed

The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects

Hypercholesteremia

China
Theravance Biopharma

Completed

Single and Multiple Ascending Dose, First-in- Human Study in Healthy Subjects

Healthy

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

Study of Bioavailability, Pharmacodynamics and Safety of SHR-1209 Administered by Single Subcutaneous Injection at Different Sites in Healthy Volunteers

Hypercholesterolemia and Hyperlipidemia

China
KBP Biosciences

Completed

Safety, Tolerability and Pharmacokinetics of KBP-7072

Healthy

United States
KBP Biosciences
Parexel

Completed

Study of KBP-7072 in Healthy Male and Female Subjects

Healthy Subjects

United States
Chinese Academy of Medical Sciences, Fuwai Hospital

Active, not recruiting

Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP)

Primary Hypertension

China
Beijing Anzhen Hospital
The George Institute for Global Health, Australia; The George Institute for... and other collaborators

Recruiting

Cardiovascular Risk Reduction in Atrial Fibrillation Trial (CRAFT)

Hypertension | Atrial Fibrillation

China
Washington University School of Medicine
The Foundation for Barnes-Jewish Hospital; MorphoSys AG; Swim Across America; Daniel...

Recruiting

Tulmimetostat (CPI-0209) in Patients With Mycosis Fungoides and Sézary Syndrome

Mycosis Fungoides | Sezary Syndrome | Mycosis Fungoides/Sezary Syndrome

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With Hyperlipidemia

Hyperlipidemia

China
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Phase I Clinical Study of the Safety， Tolerability，Pharmacokinetics, and Initial Efficacy of HRS-6209 Monotherapy in Patients With Advanced Solid Tumors

Advanced Solid Tumors
China National Center for Cardiovascular Diseases
Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen, People's Republic...

Not yet recruiting

Effects of Intensive Systolic Blood Pressure Lowering Treatment on Out-of-office Blood Pressure - an Ancillary Study to Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) Study

Blood Pressure

China
KBP Biosciences

Active, not recruiting

Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe CKD (Clarion-CKD)

Chronic Kidney Diseases

China, Spain, Australia, Hungary, Malaysia, United States, Germany, Bulgaria, Serbia, Hong Kong, Georgia, Bosnia and Herzegovina, Croatia, Czechia, South Africa, Canada, Israel, Korea, Republic of, Latvia, Lithuania, Poland, Taiwan
Dong-A ST Co., Ltd.

Unknown

A Study to Evaluate the Efficacy and Safety of DA-5204

Acute Gastritis | Chronic Gastritis

Korea, Republic of
Addpharma Inc.

Not yet recruiting

Phase III Study to Evaluate the Efficacy and Safety of AD-209

Hypertension,Essential

Korea, Republic of
Aragon Pharmaceuticals, Inc.

Active, not recruiting

Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)

Prostate Cancer

United States
Aragon Pharmaceuticals, Inc.

Completed

14C-ARN-509 Microtracer Label AME and Absolute BA Study

Healthy

Netherlands
Sangamo Therapeutics

Completed

Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS) (ALS)

Amyotrophic Lateral Sclerosis

United States
China National Center for Cardiovascular Diseases

Completed

Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) Study (ESPRIT)

Hypertension

China
Vertex Pharmaceuticals Incorporated

Completed

A Magnetic Resonance Imaging Study and Arthroscopic Biopsy Substudy in Subjects With Active Rheumatoid Arthritis Receiving VX-509, an Oral JAK3 Inhibitor

Rheumatoid Arthritis

United States, Denmark, Estonia, Lithuania, Netherlands, South Africa
Nouscom SRL
Merck Sharp & Dohme LLC

Recruiting

Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors

Solid Tumor, Adult

United States, Spain, Italy, Canada, Belgium, United Kingdom
Hospital Israelita Albert Einstein
Ministry of Health, Brazil

Active, not recruiting

Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Stroke Patients (OPTIMAL Stroke)

Vascular Diseases | Ischemic Stroke | Cognitive Impairment | Blood Pressure

Brazil
KBio Inc

Completed

KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers

Covid19

United States, Canada
Pfizer

Completed

A Study of ARRY-520 in Patients With Advanced Myeloid Leukemia

Acute Myeloid Leukemia | Advanced MDS

United States
Arrowhead Pharmaceuticals

Completed

Safety and Tolerability Study of ARC-520 in Healthy Volunteers

Healthy

Australia
National Eye Institute (NEI)

Completed

Palomid 529 in Patients With Neovascular Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
Vertex Pharmaceuticals Incorporated

Completed

Single and Multiple Dose Escalation Study of VX-509 in Healthy Subjects

Healthy

United States
Bayer

Completed

Wellnara Post-marketing Surveillance in Japan (WELLNARA)

Osteoporosis, Postmenopausal

Japan
Gilead Sciences

Recruiting

Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis (PALEKONA)

Ulcerative Colitis

United States, Australia, United Kingdom, Korea, Republic of, Japan, Canada, Switzerland
Constellation Pharmaceuticals

Recruiting

A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas

Lymphoma, T-Cell | Mesothelioma, Malignant | Advanced Solid Tumor | Endometrial Cancer | Diffuse Large B Cell Lymphoma | Ovarian Clear Cell Carcinoma | Prostatic Neoplasms, Castration-Resistant

United States, Korea, Republic of, France, United Kingdom, Italy, Spain, Poland
Amgen

Completed

AMG 529 First in Human Study

Cardiovascular

United States

Search clinical trials for: KBP-5209

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations